CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 30 enrolled
Drug / intervention
Gebauer Ethyl Chloride +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03054740
NCT03054740Phase 4Completed
CompareCT.gov

Will Patients Perceive a Vapocoolant Spray to be Effective in Reducing Pain and Increasing Satisfaction With Insertion at an Intravenous Site?

Aultman Health Foundation·interventional·Posted Feb 16, 2017·Updated Oct 3, 2018

In Brief

A Phase 4 clinical trial evaluating Gebauer Ethyl Chloride and Nature's Tears for Pain. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The primary purpose of this study is to determine if by offering a vapocoolant (cold spray) to hospital outpatients prior to an intravenous catheter (IV) insertion will increase patient satisfaction of IV insertion as well as determine if pain of insertion is decreased.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedFeb 16, 2017
Enrollment StartFeb 27, 2017
Primary CompletionApr 28, 2017
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 9.4 years ago

Interventions

Gebauer Ethyl Chloridedrug

Will be administered according to manufacturers recommendations which is to spray the aerosol can for 4-10 seconds from a distance of 3 to 9 inches. Do not spray longer than 10 seconds.

Nature's Tearsdrug

Sterile water mist will be administered 1-2 sprays prior to intravenous access